Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	5,740	3,474	1,523	678	1,352	1,940
Market Cap Growth	273.47%	128.05%	124.84%	-49.89%	-30.30%	36.21%
Enterprise Value	5,867	3,480	1,554	515.48	1,309	1,649
Last Close Price	60.89	38.21	17.42	8.99	21.03	31.04

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Forward PE	16.04	38.08	42.85	42.85	42.85	42.85
PEG Ratio	-	2.20	2.20	2.20	2.20	2.20
PS Ratio	9.71	7.08	6.53	4.67	12.35	14.71
PB Ratio	233.84	30.26	25.79	3.37	31.55	6.42
P/TBV Ratio	-	3550.82	-	6.93	-	12.09
P/FCF Ratio	61.92	91.95	-	-	-	-
P/OCF Ratio	61.92	91.95	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	9.92	7.09	6.67	3.55	11.96	12.51
EV/FCF Ratio	63.29	92.11	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	24.91	2.81	5.54	1.99	9.41	0.85
Debt / EBITDA Ratio	26.92	-	-	-	-	-
Debt / FCF Ratio	6.66	8.70	-	-	-	-
Net Debt / Equity Ratio	5.21	0.05	0.52	-0.81	-1.00	-0.96
Net Debt / EBITDA Ratio	5.57	-2.85	-0.11	0.46	0.14	1.56
Net Debt / FCF Ratio	1.38	0.16	-0.13	0.58	0.23	14.62
Asset Turnover	0.84	0.82	0.34	0.20	0.15	0.19
Inventory Turnover	0.26	0.31	0.23	0.64	0.75	0.51
Quick Ratio	3.75	2.52	1.98	3.31	3.28	4.58
Current Ratio	4.05	2.74	2.08	3.47	3.42	4.70
Return on Equity (ROE)	-95.80%	-57.80%	-246.75%	-308.90%	-192.18%	-84.66%
Return on Assets (ROA)	-5.73%	-10.69%	-46.85%	-53.15%	-44.18%	-28.87%
Return on Invested Capital (ROIC)	-25.65%	-60.82%	-503.40%	-1999.99%	-5660.75%	-381.04%
Return on Capital Employed (ROCE)	-7.41%	-14.98%	-64.48%	-68.01%	-54.07%	-34.17%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
FCF Yield	1.62%	1.09%	-	-	-	-
Buyback Yield / Dilution	-7.89%	-13.09%	-6.22%	-16.48%	-6.56%	-25.86%
Total Shareholder Return	-7.89%	-13.09%	-6.22%	-16.48%	-6.56%	-25.86%

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Aug 4, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error